Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the N680S Polymorphism of the FSHR Gene and Its Relationship With the Type of Gonadotropin Used in Controlled Ovarian Stimulation

NCT04122729 is registered in ClinicalTrials.gov with Angelini Farmacéutica as lead sponsor.

NCT NCT04122729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04122729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the N680S Polymorphism of the FSHR Gene and Its Relationship With the Type of Gonadotropin Used in Controlled Ovarian Stimulation
Lead sponsor
Angelini Farmacéutica
Phase
Observational
Overall status
Unknown status
Start date
September 25, 2019
Completion date
June 30, 2020
Enrollment
300 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

controlled ovarian stimulation, in vitro fertilization